ArticleDiabetes research and clinical practice2021

Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetes.

Amanda Leiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.